705
Views
50
CrossRef citations to date
0
Altmetric
Review Article

Kallikrein-related peptidases (KLKs) and the hallmarks of cancer

, , &
Pages 277-291 | Received 19 Oct 2015, Accepted 12 Feb 2016, Published online: 05 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maximilian Riedel, Holger Bronger, Viktor Magdolen & Tobias Dreyer. (2021) The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancer. Expert Review of Molecular Diagnostics 21:6, pages 535-545.
Read now

Articles from other publishers (49)

Ling Tang, Liyuan Wang, Feng Jin, Yuehan Hao, Tianming Zhao, Wenxu Zheng & Zhiyi He. (2023) Inflammatory regulation by restraining M2 microglial polarization: Neurodestructive effects of Kallikrein-related peptidase 8 activation in intracerebral hemorrhage. International Immunopharmacology 124, pages 110855.
Crossref
Adriana Stuardo-Parada, Rodrigo López-Muñoz, Franz Villarroel-Espindola, Carlos D. Figueroa & Pamela Ehrenfeld. (2023) Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer. Medical Oncology 40:8.
Crossref
Hannu Koistinen, Ruusu‐Maaria Kovanen, Morley D. Hollenberg, Antoine Dufour, Evette S. Radisky, Ulf‐Håkan Stenman, Jyotsna Batra, Judith Clements, John D. Hooper, Eleftherios Diamandis, Oliver Schilling, Antti Rannikko & Tuomas Mirtti. (2023) The roles of proteases in prostate cancer. IUBMB Life 75:6, pages 493-513.
Crossref
Xiaodi Lv, Zixian Mao, Xianjun Sun & Baojun Liu. (2023) Intratumoral Heterogeneity in Lung Cancer. Cancers 15:10, pages 2709.
Crossref
Kyungmin Ji & Bonnie F. Sloane. 2023. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology 712 726 .
Tove Wikström, Sanna Abrahamsson, Johan Bengtsson‐Palme, Joakim Ek, Pihla Kuusela, Elham Rekabdar, Peter Lindgren, Ulla‐Britt Wennerholm, Bo Jacobsson, Lil Valentin & Henrik Hagberg. (2022) Microbial and human transcriptome in vaginal fluid at midgestation: Association with spontaneous preterm delivery. Clinical and Translational Medicine 12:9.
Crossref
Hayet Bouzid, Feryel Soualmia, Katerina Oikonomopoulou, Antoninus Soosaipillai, Francine Walker, Khaoula Louati, Rea Lo Dico, Marc Pocard, Chahrazade El Amri, Natalia A. Ignatenko & Dalila Darmoul. (2022) Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis. Biomolecules 12:7, pages 1003.
Crossref
Shunqing Zhou, Shuyan Liu, Geng Tian, Lin Zhao, Haichen Wang, Ying Li, Yannan Shen & Liying Han. (2022) KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer. Gynecologic Oncology 166:1, pages 138-147.
Crossref
Fengyi Xiang, Yueqing Wang, Chunyu Cao, Qingyun Li, Hao Deng, Jun Zheng, Xiaowen Liu & Xiao Tan. (2022) The Role of Kallikrein 7 in Tumorigenesis. Current Medicinal Chemistry 29:15, pages 2617-2631.
Crossref
Srilakshmi Srinivasan, Thomas Kryza, Jyotsna Batra & Judith Clements. (2022) Remodelling of the tumour microenvironment by the kallikrein-related peptidases. Nature Reviews Cancer 22:4, pages 223-238.
Crossref
Carlos D. Figueroa & Kanti D. Bhoola. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 678 693 .
Hannu Koistinen, Jaana Künnapuu & Michael Jeltsch. (2021) KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?. International Journal of Molecular Sciences 22:24, pages 13545.
Crossref
Anamarija Habič, Metka Novak, Bernarda Majc, Tamara Lah Turnšek & Barbara Breznik. (2021) Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment. Journal of Histochemistry & Cytochemistry 69:12, pages 775-794.
Crossref
Qing Hua, Zhirong Sun, Yi Liu, Xuefang Shen, Weiwei Zhao, Xiaoyan Zhu & Pingbo Xu. (2021) KLK8 promotes the proliferation and metastasis of colorectal cancer via the activation of EMT associated with PAR1. Cell Death & Disease 12:10.
Crossref
Richard J. Epstein. (2021) The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor. Tumor Biology 43:1, pages 159-176.
Crossref
Eitan Rabinovitch, Koishiro Mihara, Amiram Sananes, Marianna Zaretsky, Michael Heyne, Julia Shifman, Amir Aharoni, Morley D. Hollenberg & Niv Papo. (2021) A KLK4 proteinase substrate capture approach to antagonize PAR1. Scientific Reports 11:1.
Crossref
Qing Hua, Tianjiao Li, Yixuan Liu, Xuefang Shen, Xiaoyan Zhu & Pingbo Xu. (2021) Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer. Frontiers in Oncology 11.
Crossref
Matej Vizovisek, Dragana Ristanovic, Stefano Menghini, Michael G. Christiansen & Simone Schuerle. (2021) The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy. International Journal of Molecular Sciences 22:5, pages 2514.
Crossref
Xiaorong Yang, Chen Suo, Tongchao Zhang, Xiaolin Yin, Jinyu Man, Ziyu Yuan, Jingru Yu, Li Jin, Xingdong Chen, Ming Lu & Weimin Ye. (2021) Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study. Biomarker Research 9:1.
Crossref
Márcia Gaião Alves, Márcio Hideki Kodama, Elaine Zayas Marcelino da Silva, Bruno Belmonte Martinelli Gomes, Rodrigo Alberto Alves da Silva, Gabriel Viliod Vieira, Vani Maria Alves, Carol Kobori da Fonseca, Ana Carolina Santana, Nerry Tatiana Cecílio, Mara Silvia Alexandre Costa, Maria Célia Jamur, Constance Oliver, Thiago Mattar Cunha, Thomas H. Bugge, Paulo Henrique Braz-Silva, Leandro M. Colli & Katiuchia Uzzun Sales. (2021) Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma. Translational Oncology 14:1, pages 100970.
Crossref
Torsten Voigtländer, Jochen Metzger, Holger Husi, Martha M. Kirstein, Martin Pejchinovski, Agnieszka Latosinska, Maria Frantzi, William Mullen, Thorsten Book, Harald Mischak & Michael P. Manns. (2020) Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma. Journal of Biomedical Science 27:1.
Crossref
Weiwei Gong, Yueyang Liu, Sarah Preis, Xiaocong Geng, Agnes Petit-Courty, Marion Kiechle, Alexander Muckenhuber, Tobias Dreyer, Julia Dorn, Yves Courty & Viktor Magdolen. (2020) Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients. Molecular Medicine 26:1.
Crossref
Agathe Quesnel, George S. Karagiannis & Panagiota S. Filippou. (2020) Extracellular proteolysis in glioblastoma progression and therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:2, pages 188428.
Crossref
Cinthia Mella, Carlos D. Figueroa, Carola Otth & Pamela Ehrenfeld. (2020) Involvement of Kallikrein-Related Peptidases in Nervous System Disorders. Frontiers in Cellular Neuroscience 14.
Crossref
Katherine Falkowski, Ewa Bielecka, Ida B. Thøgersen, Oliwia Bocheńska, Karolina Płaza, Magdalena Kalińska, Laura Sąsiadek, Małgorzata Magoch, Aleksandra Pęcak, Magdalena Wiśniewska, Natalia Gruba, Magdalena Wysocka, Anna Wojtysiak, Magdalena Brzezińska-Bodal, Kamila Sychowska, Anastasija Pejkovska, Maren Rehders, Georgina Butler, Christopher M Overall, Klaudia Brix, Grzegorz Dubin, Adam Lesner, Andrzej Kozik, Jan J. Enghild, Jan Potempa & Tomasz Kantyka. (2020) Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)—A CleavEx Based Analysis. International Journal of Molecular Sciences 21:12, pages 4383.
Crossref
Panagiota S. Filippou, George S. Karagiannis & Anastasia Constantinidou. (2019) Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene 39:10, pages 2040-2054.
Crossref
Panagiota S. Filippou, Annie H. Ren, Antoninus Soosaipillai, Roaa Safar, Ioannis Prassas, Eleftherios P. Diamandis & James R. Conner. (2020) Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response. Clinical Biochemistry 77, pages 41-47.
Crossref
Jee Suk Chang, Nalee Kim, Ji-Ye Kim, Sung-Im Do, Yeona Cho, Hyun-Soo Kim & Yong Bae Kim. (2020) Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer. Journal of Gynecologic Oncology 31:6.
Crossref
Thomas Kryza, Nathalie Bock, Scott Lovell, Anja Rockstroh, Melanie L. Lehman, Adam Lesner, Janaththani Panchadsaram, Lakmali Munasinghage Silva, Srilakshmi Srinivasan, Cameron E. Snell, Elizabeth D. Williams, Ladan Fazli, Martin Gleave, Jyotsna Batra, Colleen Nelson, Edward W. Tate, Jonathan Harris, John D. Hooper & Judith A. Clements. (2019) The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer. Molecular Oncology 14:1, pages 105-128.
Crossref
Mengwei Wu, Xiaobin Li, Taiping Zhang, Ziwen Liu & Yupei Zhao. (2019) Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Frontiers in Oncology 9.
Crossref
Jun Lu, Qin Shi, Lele Zhang, Jun Wu, Yuqing Lou, Jie Qian, Bo Zhang, Shuyuan Wang, Huimin Wang, Xiaodong Zhao & Baohui Han. (2019) Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line. Frontiers in Oncology 9.
Crossref
Tooba Yousefi, Seyed Mostafa Mir, Jahanbakhsh Asadi, Mehdi Tourani, Ansar Karimian, Mahmood Maniati & Sadra Samavarchi Tehrani. (2019) In silico analysis of non-synonymous single nucleotide polymorphism in a human KLK-2 gene associated with prostate cancer. Meta Gene 21, pages 100578.
Crossref
Afshin Moradi, Srilakshmi Srinivasan, Judith Clements & Jyotsna Batra. (2019) Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment. Cancer and Metastasis Reviews 38:3, pages 333-346.
Crossref
Luis Rivera Sanchez, Lucia Borriello, David Entenberg, John S Condeelis, Maja H Oktay & George S Karagiannis. (2019) The emerging roles of macrophages in cancer metastasis and response to chemotherapy. Journal of Leukocyte Biology 106:2, pages 259-274.
Crossref
Kajsa Björkman, Harri Mustonen, Tuomas Kaprio, Caj Haglund & Camilla Böckelman. (2019) Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay. Tumor Biology 41:7, pages 101042831986072.
Crossref
Farhana Matin, Varinder Jeet, Srilakshmi Srinivasan, Alexandre S Cristino, Janaththani Panchadsaram, Judith A Clements & Jyotsna Batra. (2019) MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer. Clinical Chemistry 65:6, pages 771-780.
Crossref
Paula Kurtz, Amanda E. Jones, Bhavana Tiwari, Nichole Link, Annika Wylie, Charles Tracy, Helmut Krämer & John M. Abrams. (2019) Drosophila p53 directs nonapoptotic programs in postmitotic tissue . Molecular Biology of the Cell 30:11, pages 1339-1351.
Crossref
Honghai Ma, Alexandra Hockla, Christine Mehner, Matt Coban, Niv Papo, Derek C. Radisky & Evette S. Radisky. (2019) PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma. Scientific Reports 9:1.
Crossref
Sadra Samavarchi Tehrani, Hamideh Mahmoodzadeh Hosseini, Tooba Yousefi, Maryam Abolghasemi, Durdi Qujeq, Mahmood Maniati & Jafar Amani. (2018) The crosstalk between trace elements with DNA damage response, repair, and oxidative stress in cancer. Journal of Cellular Biochemistry 120:2, pages 1080-1105.
Crossref
Elena De Vita, Peter Schüler, Scott LovellJasmin Lohbeck, Sven Kullmann, Eitan Rabinovich, Amiram Sananes, Bernd Heßling, Veronique HamonNiv Papo, Jochen Hess, Edward W. Tate, Nikolas Gunkel & Aubry K. Miller. (2018) Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular Activity. Journal of Medicinal Chemistry 61:19, pages 8859-8874.
Crossref
Carlos D. Figueroa, Luis Molina, Kanti D. Bhoola & Pamela Ehrenfeld. (2018) Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer. Biological Chemistry 399:9, pages 937-957.
Crossref
Panagiota S. Filippou, Annie H. Ren, Antoninus Soosaipillai, Michail-Dimitrios Papaioannou, Dimitrios Korbakis, Roaa Safar, Eleftherios P. Diamandis & James R. Conner. (2018) Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis. Clinical Biochemistry 59, pages 78-85.
Crossref
Panagiota S. Filippou, Annie H. Ren, Sudarshan Bala, Michail-Dimitrios Papaioannou, Davor Brinc, Ioannis Prassas, Theano Karakosta & Eleftherios P. Diamandis. (2018) Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer. Clinical Biochemistry 58, pages 108-115.
Crossref
Laiqin Tang, Zhiguo Long, Na Zhao, Guangjia Feng, Xianzhi Guo & Minghua Yu. (2018) NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer. Journal of Cellular Biochemistry 119:8, pages 6398-6407.
Crossref
Jian Ping Du, Lin Li, Jun Zheng, Ding Zhang, Wei Liu, Wei Hong Zheng, Xiao Song Li, Ru Cheng Yao, Fangyu Wang, Sen Liu & Xiao Tan. (2018) Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer. Oncotarget 9:16, pages 12894-12906.
Crossref
Panagiota Filippou, Dimitrios Korbakis, Sofia Farkona, Antoninus Soosaipillai, Theano Karakosta & Eleftherios P. Diamandis. (2017) A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9. Clinical Proteomics 14:1.
Crossref
Tiphaine Delaunay, Lydia Deschamps, Meriem Haddada, Francine Walker, Antoninus Soosaipillai, Feryel Soualmia, Chahrazade El Amri, Eleftherios P. Diamandis, Maria Brattsand, Viktor Magdolen & Dalila Darmoul. (2017) Aberrant expression of kallikrein‐related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion. Molecular Oncology 11:10, pages 1330-1347.
Crossref
Xin Zheng, Mengxi He, Xiao Tan, Jun Zheng, Fangyu Wang & Sen Liu. (2017) 3D-quantitative structure–activity relationship and docking studies of coumarin derivatives as tissue kallikrein 7 inhibitors. Journal of Pharmacy and Pharmacology 69:9, pages 1136-1144.
Crossref
Panagiota S. Filippou, Sofia Farkona, Davor Brinc, Yijing Yu, Ioannis Prassas & Eleftherios P. Diamandis. (2017) Biochemical and functional characterization of the human tissue kallikrein 9. Biochemical Journal 474:14, pages 2417-2433.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.